CADM1 was expressed in 14 of 88 (16%) PTCL-NOS cases, and its expression was associated with C-C chemokine receptor type 4 (CCR4) expression and nuclear atypia. This evidence concerns the gene CCR4 and mature T-cell and NK-cell non-Hodgkin lymphoma.